CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis

CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis

Номзүйн дэлгэрэнгүй
Үндсэн зохиолчид:	Lutgens, E, Mulder, WJM, Monaco, C
Бусад зохиолчид:	CHECKPOINT ATHERO consortium
Формат:	Journal article
Хэл сонгох:	English
Хэвлэсэн:	Oxford University Press 2023

Ижил төстэй зүйлс

Risk factors in coronary atherosclerosis athero-inflammation: the meeting point
-н: Altman Raul
Хэвлэсэн: (2003-07-01)

Immune checkpoints as therapeutic targets in autoimmunity
-н: Paluch, C, зэрэг
Хэвлэсэн: (2018)

Acute coronary disease Athero-Inflammation: Therapeutic approach
-н: Altman Raul
Хэвлэсэн: (2003-06-01)

The ATHERO-AF Study
-н: Michael D. Ezekowitz, MBChB, DPhil, зэрэг
Хэвлэсэн: (2024-08-01)

Immune Checkpoints as Therapeutic Targets in Autoimmunity
-н: Christopher Paluch, зэрэг
Хэвлэсэн: (2018-10-01)

Cell-specific and athero-protective roles for RIPK3 in a murine model of atherosclerosis
-н: Sarah Colijn, зэрэг
Хэвлэсэн: (2020-01-01)

Impact of immune checkpoint inhibitors on atherosclerosis progression in patients with lung cancer
-н: Pal Maurovich-Horvat, зэрэг
Хэвлэсэн: (2023-07-01)

Statins and immune checkpoint inhibitors: a strategy to improve the efficacy of immunotherapy for cancer?
-н: Esther Lutgens, зэрэг
Хэвлэсэн: (2022-09-01)

miRNA-Based Therapeutics in the Era of Immune-Checkpoint Inhibitors
-н: Florian Huemer, зэрэг
Хэвлэсэн: (2021-01-01)

Cancer patients receiving immune checkpoint inhibitor therapy are at an increased risk for atherosclerotic cardiovascular disease
-н: Esther Lutgens, зэрэг
Хэвлэсэн: (2020-05-01)

Prognostic significance and therapeutic potentials of immune checkpoints in osteosarcoma
-н: Vafa Meftahpour, зэрэг
Хэвлэсэн: (2022-01-01)

Therapeutic Ultrasound-Enhanced Immune Checkpoint Inhibitor Therapy
-н: Jinyun Yuan, зэрэг
Хэвлэсэн: (2021-03-01)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
-н: Naoki Hama, зэрэг
Хэвлэсэн: (2022-01-01)

Immune checkpoint inhibitors of PD-L1 as cancer therapeutics
-н: Akintunde Akinleye, зэрэг
Хэвлэсэн: (2019-09-01)

Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade
-н: Naoki Hama, зэрэг
Хэвлэсэн: (2020-10-01)

From immune checkpoints to therapies: understanding immune checkpoint regulation and the influence of natural products and traditional medicine on immune checkpoint and immunotherapy in lung cancer
-н: Yibin Zhou, зэрэг
Хэвлэсэн: (2024-02-01)

Soluble immune checkpoints: implications for cancer prognosis and response to immune checkpoint therapy and conventional therapies
-н: Stephanie C. Pitts, зэрэг
Хэвлэсэн: (2024-05-01)

Immune Checkpoint Blockade Enhances Immune Activity of Therapeutic Lung Cancer Vaccine
-н: Pournima Kadam, зэрэг
Хэвлэсэн: (2020-11-01)

Immune checkpoint molecules in prevention and development of asthma
-н: Zahra Kanannejad, зэрэг
Хэвлэсэн: (2023-02-01)

Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
-н: Esther Lutgens, зэрэг
Хэвлэсэн: (2021-06-01)

Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition
-н: Jared M. Newton, зэрэг
Хэвлэсэн: (2019-08-01)

The Alcohol–High-Density Lipoprotein Athero-Protective Axis
-н: Corina Rosales, зэрэг
Хэвлэсэн: (2020-07-01)

Immune checkpoint analysis in ear cancer
-н: M. Klein, зэрэг
Хэвлэсэн: (2023-11-01)

Biomarkers for immune checkpoint blockers
-н: Kirsty Wienand, зэрэг
Хэвлэсэн: (2018-06-01)

Immune Checkpoints in Viral Infections
-н: Huiming Cai, зэрэг
Хэвлэсэн: (2020-09-01)

Immune checkpoint blockade in HIV
-н: Celine Gubser, зэрэг
Хэвлэсэн: (2022-02-01)

Immune Checkpoint Inhibitors and the Heart
-н: Diana Larisa Mocan-Hognogi, зэрэг
Хэвлэсэн: (2021-09-01)

Structural basis for the pathophysiology of lipoprotein(a) in the athero-thrombotic process
-н: E. Anglés-Cano
Хэвлэсэн: (1997-11-01)

Metabolic modulation of melanoma enhances the therapeutic potential of immune checkpoint inhibitors
-н: Zafer Gurel, зэрэг
Хэвлэсэн: (2024-10-01)

Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint Inhibitors
-н: Magalie Dosset, зэрэг
Хэвлэсэн: (2020-07-01)

Therapeutic Targeting of the Macrophage Immune Checkpoint CD47 in Myeloid Malignancies
-н: Mark P. Chao, зэрэг
Хэвлэсэн: (2020-01-01)

Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets
-н: Xueyin Zhou, зэрэг
Хэвлэсэн: (2022-05-01)

Immune Checkpoints: Novel Therapeutic Targets to Attenuate Sepsis-Induced Immunosuppression
-н: Margaret A. McBride, зэрэг
Хэвлэсэн: (2021-02-01)

Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases
-н: Yujia Zhai, зэрэг
Хэвлэсэн: (2021-04-01)

Therapeutic Monoclonal Antibodies Targeting Immune Checkpoints for the Treatment of Solid Tumors
-н: Nicholas Gravbrot, зэрэг
Хэвлэсэн: (2019-10-01)

Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
-н: Alice Mougel, зэрэг
Хэвлэсэн: (2019-03-01)

Editorial: Co-inhibitory immune checkpoint proteins as biomarkers and therapeutic targets in cancer
-н: Caroline E. Nunes-Xavier
Хэвлэсэн: (2024-09-01)

Low HDL-C level is associated with the development of intracranial artery stenosis: analysis from the Chinese IntraCranial AtheroSclerosis (CICAS) study.
-н: Yining Qian, зэрэг
Хэвлэсэн: (2013-01-01)

Editorial: The therapeutic inhibition of macrophage checkpoints
-н: Alexandre P. A. Theocharides, зэрэг
Хэвлэсэн: (2024-04-01)

CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.
-н: Kuang-Yuh Chyu, зэрэг
Хэвлэсэн: (2012-01-01)